On May 13th, 2010, Medical School of Kurume University announced to start the new clinical trial regarding “cancer peptide vaccine therapy” against lung cancer, liver cancer and vaginal cystocele. The school is looking for patients who have ideas to receive this therapy.

 ”Cancer peptide vaccine therapy” of the school is that doctors administer 31 vaccines, which the school developed originally, to patients according to their blood types and immune bodies in order to excite their immune functions. Comparing with anticancer drug treatment and radiation therapy, the therapy has few side-effects. The school has administered the vaccines about 1000 patients over the past ten years in order to put it into practical use. Although the school has administered the vaccines to patients, some of them were ineffective. But there were some cases which progressions of cancer of some patients stopped and the patients could live longer than the life expectancy.

 The school will select the patients who fit the condition of clinical trial and divide two groups, and then administers the vaccines to one group and don’t administer the vaccines to another. The school will test the effectiveness of the vaccine for 4 years.